Co-Diagnostics Inc (CODX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,885 | 11,444 | 11,115 | 1,903 | 2,937 |
| Marketable Securities | N/A | N/A | 2,248 | 19,576 | 26,811 |
| Receivables | 235 | 979 | 211 | 136 | 133 |
| Inventories | 992 | 1,090 | 1,085 | 1,083 | 1,073 |
| TOTAL | $13,694 | $14,055 | $15,307 | $23,832 | $32,292 |
| Non-Current Assets | |||||
| PPE Net | 2,272 | 2,485 | 2,673 | 2,594 | 2,761 |
| Investments And Advances | 351 | 660 | 716 | 730 | 294 |
| Intangibles | 7,219 | 26,101 | 26,101 | 26,101 | 26,101 |
| Other Non-Current Assets | 1,207 | 1,440 | 1,668 | 1,894 | 2,115 |
| TOTAL | $11,049 | $30,686 | $31,159 | $31,318 | $31,272 |
| Total Assets | $24,743 | $44,741 | $46,466 | $55,149 | $63,563 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,878 | 1,458 | 1,635 | 2,713 | 3,294 |
| Accrued Expenses | 865 | 1,205 | 1,008 | 1,611 | 2,562 |
| Other current liabilities | 119 | 240 | 198 | 109 | 503 |
| TOTAL | $3,540 | $3,693 | $3,711 | $5,377 | $7,316 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 15 | 46 | 46 | 41 | 41 |
| Other Non-Current Liabilities | 574 | 728 | 879 | 1,127 | 1,659 |
| TOTAL | $574 | $1,220 | $1,616 | $1,852 | $2,372 |
| Total Liabilities | $4,114 | $4,913 | $5,327 | $7,229 | $9,688 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,602 | 2,028 | 1,283 | 1,123 | 1,118 |
| Common Shares | 68 | 53 | 41 | 38 | 38 |
| Retained earnings | -80,374 | -54,191 | -48,304 | -40,574 | -33,478 |
| Other shareholders' equity | 424 | 519 | 558 | 755 | 843 |
| TOTAL | $20,629 | $39,828 | $41,138 | $47,921 | $53,875 |
| Total Liabilities And Equity | $24,743 | $44,741 | $46,466 | $55,149 | $63,563 |